To the best of our knowledge, none previously compared sequential measurements of conventional biomarkers such as PCT, C-RP, and other laboratory tests such as lymphocytes, NT-pro-BNP, LDH with MR-proADM values in a cohort of COVID-19 critically ill patients admitted in ICU. This evidence concerns the gene NPPB and COVID-19.